Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model

No abstract is available for this paper.

• Publication year

  2003

• Venue

  NeuroImage

• Publication date

  2003-10-01

• Fields of study

  Chemistry, Medicine, Computer Science

• Identifiers
  DOI 10.1016/S1053-8119(03)00348-3PMID 14568476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single cell studies of the primate putamen

  2004cited by this paper
• Selective neuronal discharge in monkey putamen reflects intended direction of planned limb movements

  2004cited by this paper
• Single cell studies of the primate putamen

  2004cited by this paper
• Positron emission tomography (PET): Expanding the horizons of oncology drug development

  2003cited by this paper
• Dopamine receptors in Parkinson's disease: imaging studies.

  2003cited by this paper
• Functional brain imaging in Parkinson's disease.

  2003cited by this paper
• Functional neuroanatomy of the basal ganglia in Parkinson's disease.

  2003cited by this paper
• Downregulation of Striatal Dopamine D2 Receptors in Advanced Parkinson’s Disease Contributes to the Development of Motor Fluctuation

  2002influential reference
• Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries.

  2002cited by this paper
• Validation and calibration of physical activity monitors in children.

  2002cited by this paper
• Cerebral blood flow activation studies in Parkinson's disease.

  2001cited by this paper
• Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.

  2001cited by this paper
• Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years

  2001cited by this paper
• SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.

  2001cited by this paper
• [123I]β-CIT SPECT imaging assessment of the rate of Parkinson’s disease progression

  2001cited by this paper
• Deep brain stimulation for Parkinson's disease.

  2001cited by this paper
• Improved surgical cell therapy in Parkinson's disease. Physiological basis and new transplantation methodology.

  2001cited by this paper
• [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.

  2001cited by this paper
• Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG‐PET

  2001cited by this paper
• Neurochemical findings in the MPTP model of Parkinson's disease

  2001influential reference
• The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT

  2001cited by this paper
• Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.

  2001cited by this paper
• In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long‐term MPTP‐induced parkinsonism

  2000cited by this paper
• Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET

  2000cited by this paper
• Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.

  2000cited by this paper
• Functional imaging of Parkinson's disease: is it possible to detect brain areas for specific symptoms?

  1999cited by this paper
• Genetic and environmental factors in the pathogenesis of Parkinson's disease.

  1999cited by this paper
• SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease.

  1999cited by this paper
• Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease.

  1999cited by this paper
• Differential Diagnosis of Parkinsonism

  1999cited by this paper
• Epidemiologic approaches to the study of Parkinson's disease etiology.

  1999cited by this paper
• Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia

  1999cited by this paper
• Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease

  1998cited by this paper
• Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET

  1998cited by this paper
• PET and SPECT studies in Parkinson's disease.

  1997cited by this paper
• Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing.

  1997cited by this paper
• Regional metabolic correlates of surgical outcomes following unilateral pallidotomy for parkinson's disease

  1996cited by this paper
• Cocaine congeners as PET imaging probes for dopamine terminals.

  1996influential reference
• Neurotoxicity and the mechanisms of cell death in Parkinson's disease.

  1996cited by this paper
• The role of the environment in Parkinson's disease.

  1996cited by this paper
• Functional and pathophysiological models of the basal ganglia.

  1996cited by this paper
• Neurotoxicity and the mechanisms of cell death in Parkinson's disease

  1996cited by this paper
• Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.

  1995cited by this paper
• Early differential diagnosis of Parkinson's disease with 18F‐fluorodeoxyglucose and positron emission tomography

  1995cited by this paper
• Functional Brain Imaging

  1995cited by this paper
• Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.

  1995cited by this paper
• Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls

  1995cited by this paper
• Functional brain imaging.

  1995cited by this paper
• Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT.

  1994influential reference
• Cortical glucose metabolism in Parkinson's disease without dementia.

  1994cited by this paper
• The Metabolic Topography of Parkinsonism

  1994cited by this paper
• Distribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with [3H]CFT and [125I]RTI‐55

  1992cited by this paper
• Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism

  1992cited by this paper
• Parkinson's disease.

  1992cited by this paper
• Cerebral Metabolic Effects of Monoamine Oxidase Inhibition in Normal and 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Acutely Treated Monkeys

  1991cited by this paper
• Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP

  1990cited by this paper
• Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

  1990cited by this paper
• Developments in high‐resolution positron emission tomography at MGH

  1989influential reference
• Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

  1988cited by this paper
• Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate.

  1987cited by this paper
• Parallel organization of functionally segregated circuits linking basal ganglia and cortex.

  1986cited by this paper
• [Parkinson disease].

  1985cited by this paper
• Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose

  1985influential reference
• Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey.

  1985influential reference
• Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography: Theory, Procedure, and Normal Values

  1980cited by this paper
• Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size

  1979cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• A model for regional cerebral oxygen distribution during continuous inhalation of 15O2, C15O, and C15O2.

  1978influential reference
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977influential reference
• The continuous inhalation of oxygen-15 for assessing regional oxygen extraction in the brain of man.

  1976cited by this paper
• Systemic and Regional Blood‐flow Changes during Spinal Anesthesia in the Rhesus Monkey

  1971cited by this paper
• Systemic and Regional Blood Flow Changes during Halothane Anesthesia in the Rhesus Monkey

  1971cited by this paper
• NeuroImage

  year unknowncited by this paper

• Neuroprotective potential of isofraxidin: Alleviating parkinsonian symptoms, inflammation and microglial activation

  2025cites this paper
• The Role of Nonhuman Primates in Neurotoxicology Research: Preclinical Models and Experimental Methods

  2023cites this paper
• MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease

  2021cites this paper
• Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease

  2020cites this paper
• Changes in thalamic dopamine innervation in a progressive Parkinson's disease model in monkeys

  2019cites this paper
• Chapter 4 Manganese Inhalation Induces Dopaminergic Cell Loss : Relevance to Parkinson ’ s Disease

  2018cites this paper
• Manganese Inhalation Induces Dopaminergic Cell Loss: Relevance to Parkinson’s Disease

  2018cites this paper
• Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease

  2018cites this paper
• Quantification of motor network dynamics in Parkinson’s disease by means of landscape and flux theory

  2017cites this paper
• Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation

  2016cites this paper
• The Neuropathology of Movement Disorders in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) and Methcathinone (Ephedrone) Addictions

  2016cites this paper
• Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease.

  2015cites this paper
• Reproducibility of a Parkinsonism‐related metabolic brain network in non‐human primates: A descriptive pilot study with FDG PET

  2015cites this paper
• Proposed Motor Scoring System in a Porcine Model of Parkinson's Disease induced by Chronic Subcutaneous Injection of MPTP

  2014cites this paper
• Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease

  2014cites this paper
• Unaltered lactate and glucose transporter levels in the MPTP mouse model of Parkinson's disease

  2013cites this paper
• A Case of early onset Parkinson’s disease after major stress

  2013cites this paper
• Functional Reorganization of Motor and Limbic Circuits after Exercise Training in a Rat Model of Bilateral Parkinsonism

  2013cites this paper
• Manganese mixture inhalation is a reliable Parkinson disease model in rats.

  2012cites this paper
• Perfusion and metabolism imaging studies in Parkinson's disease.

  2012cites this paper
• PET Analysis of Dopaminergic Neurodegeneration in Relation to Immobility in the MPTP-Treated Common Marmoset, a Model for Parkinson’s Disease

  2012cites this paper
• Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.

  2012cites this paper
• Abnormal Metabolic Brain Networks in a Nonhuman Primate Model of Parkinsonism

  2012influential citation
• Evolution of Extra-Nigral Damage Predicts Behavioural Deficits in a Rat Proteasome Inhibitor Model of Parkinson's Disease

  2011cites this paper
• Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons.

  2011cites this paper
• Effects of hypoxic-ischemic brain injury on striatal dopamine transporter in newborn piglets: evaluation of 11C-CFT PET/CT for DAT quantification.

  2011cites this paper
• Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease.

  2010cites this paper
• Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson’s disease

  2010cites this paper
• [Study on brain tissue characteristics of rat model of Parkinson's disease based on functionality near-infrared spectroscopy (fNIRs) technology].

  2010cites this paper
• EFECTO DE LA ADMINISTRACIÓN CRÓNICA DE LEVODOPA SOBRE LA ACTIVIDAD FUNCIONAL DE LA VÍA NIGROESTRIADA EN MACACOS CON PARKINSONISMO INDUCIDO POR MPTP

  2010cites this paper
• Mouse models in neurological disorders: applications of non-invasive imaging.

  2010cites this paper
• Metabolic changes detected in vivo by 1H MRS in the MPTP‐intoxicated mouse

  2010cites this paper
• Subcortical elevation of metabolism in Parkinson's disease - A critical reappraisal in the context of global mean normalization

  2009cites this paper
• Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease.

  2009cites this paper
• The 3R principle and the use of non-human primates in the study of neurodegenerative diseases: the case of Parkinson's disease.

  2009cites this paper
• Anticipatory changes in regional cerebral hemodynamics: a new role for dopamine?

  2009cites this paper
• Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates

  2008cites this paper
• Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease

  2008cites this paper
• Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.

  2008cites this paper
• In-vivo PET imaging of implanted human retinal pigment epithelium cells in a Parkinson's disease rat model

  2008cites this paper
• Animal Models in Functional Magnetic Resonance Imaging

  2008cites this paper
• Untersuchung des Expressionsmusters und der Neuropathologie konditionaler Mausmodelle des Morbus Parkinson

  2008cites this paper
• Comparing the radiological anatomy, electrophysiology, and behavioral roles of the pedunculopontine and subthalamic nuclei in the normal and parkinsonian brain

  2008cites this paper
• Functional Imaging of Cerebral Blood Flow and Glucose Metabolism in Parkinson’s Disease and Huntington’s Disease

  2007cites this paper
• Subthalamic Glutamic Acid Decarboxylase Gene Therapy: Changes in Motor Function and Cortical Metabolism

  2007cites this paper
• Distribution of the dopamine innervation in the macaque and human thalamus

  2007cites this paper
• Animal Models of Neurodegenerative Disease: Insights from In vivo Imaging Studies

  2007cites this paper
• Basal Ganglia – Cortex Interactions: Regulation of Cortical Function by D1 Dopamine Receptors in the Striatum

  2007cites this paper
• Monoaminergic Modulation of Cortical Excitability

  2007cites this paper
• Modulation of Dopaminergic and Glutamatergic Brain Function: PET Studies on Parkinsonian Rats

  2007cites this paper
• Dual-modality in vivo monitoring of subventricular zone stem cell migration and metabolism.

  2007cites this paper
• Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.

  2006cites this paper
• Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.

  2006cites this paper
• Neural Repair Strategies for Parkinson's Disease: Insights from Primate Models

  2006cites this paper
• Insights into Parkinson's disease models and neurotoxicity using non-invasive imaging.

  2005influential citation
• CHAPTER B2 – MPTP-Induced Nigrostriatal Injury in Nonhuman Primates

  2005cites this paper
• Pig brain stereotaxic standard space: mapping of cerebral blood flow normative values and effect of MPTP-lesioning.

  2005cites this paper